Opioid Warning Letter To Cipher Likely Easy Call For US FDA

 
• By Sue Sutter
  
FDA entrance sign 2016
US FDA says Cipher's ConZip is misbranded by a violative sales detailing piece.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance